Healthcareblogs

  Market Highlights Periodontal Therapeutics Market Size was valued at USD 0.3 billion in 2022 and is projected to grow from USD 0.3 Billion in 2023 to USD 0.6 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 10.3% during the forecast period (2023 - 2030). Periodontal disease is an infection that occurs around the teeth which include gums, periodontal ligament and alveolar bone. The earliest stage of periodontal is gingivitis infection that affects the gums. Periodontal is mostly caused by bacteria in dental plaque sticky substance that forms on teeth. Although bacterial plaque is the main cause of periodontal disease several other factors such as medication, other diseases, and oral habit also contributes to periodontal disease.    The increasing demand for local antibiotic has resulted in a rise in research and development of local antibiotic. Owing to the increasing incidences of diabetic patients there is a rise in the periodontal therapeutic market. Where

  Market Scope Market Research Future (MRFR) The Amyotrophic Lateral Sclerosis Market   is expected to reach USD 1.08 billion at 6.10% CAGR during the forecast period 2022-2030 Major Boosters & Deterrents The amyotrophic lateral sclerosis industry will benefit from the mounting demand for innovative IT solutions that facilitate efficient value-based healthcare delivery. Massive investments in the upgradation of healthcare infrastructure, and the rampant requirement for effective disease management could have a remarkable impact on the worldwide market in subsequent years. A vital growth inducing factor can be the alarming surge in ASL cases worldwide, bolstering the need for advanced treatments as well as drugs. Large-scale R&D expenditure for better quality drugs and treatments combined with the fast- expanding medical tourism industry in developing countries like India will offer attractive opportunities to the vendors operating in the global industry. The surge in go

  Market Synopsis: Contraceptive Pills Market Size was valued at USD 20.9 billion in 2022 and is projected to grow from USD 21.4 Billion in 2023 to USD 24.3 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 2.20% during the forecast period (2023 - 2030). Contraceptive pills are likely to witness considerable demand in the years to come. The observation offered by Market Research Future (MRFR) unfolds that the global Contraceptive Pills Market is expected to enter a phase of maturity in the foreseeable future. The issue of problem explosion has encouraged the increasing consumption of contraceptive pills. It has motivated the governments to invest in its distribution for market penetration. In addition, non-profit organizations are also expected to support the use of pills. These factors are expected to expedite the revenue growth of the contraceptive pills market in the years to come. The social awakening regarding the use of these pills supported by organizati

  The Osteoarthritis Market Size was valued at USD 4.3 billion in 2022 and is projected to grow from USD 4.69 Billion in 2023 to USD 8.63 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 9.10% during the forecast period (2023 - 2030). The market is growing persistently on account of growing global geriatric population as it accounts for more disability among the elderly population than any other disease. Elderly patients have been reported to experience radiographic osteoarthritis which increases as patients age. Rising populace of obesity is also considered to be the driving factor in the growth of the global osteoarthritis market since obesity has also been identified as a risk factor for osteoarthritis. Obesity reduces the skeletal-weight-to-body-mass which results in compressive forces to joints. Competitive Landscape The Global Osteoarthritis Market Players include Regeneron (U.S.), Novartis AG (Europe), TissueGene Inc. (U.S.),

  Market Scenario The Erythropoietin Drugs Market is expected to reach USD 19,800.56 Million by 2030 at 11.2% CAGR during the forecast period 2022-2030. Erythropoietin is also known as hematopoietin. Erythropoietin is a hormone responsible for formation of red blood cells, it is secreted by kidneys and it promotes formation of red blood cells from bone marrow. This process is known as erythropoiesis. Erythropoietin has many applications such as treatment of anemia, treatment of chronic kidney diseases, AIDS and it also has applications in oncology. Synthetic forms of erythropoietin like epoetin alfa, epoetin beta, darbepoetin alfa, epoetin omega and epoetin delta have developed due to the development in the recombinant DNA technology. Epoetin alfa and darbepoetin alfa are the most popular erythropoietin drugs. They form 80% of the total Erythropoietin Drug Market . Amgen Inc. was the first company to invent epoetin alfa and darbepoetin alfa. The company patented these drugs as ep

  Organ transplantation is one of the significant developments in modern-day medicine. Organ transplantation is a medical procedure in which the organ is removed from one body and transferred to another body to replace the organ that is missing or damaged. One of the major aspects of organ transplantation is the approval of the patient or the patient's family. Organ harvesting without prior permission is illegal and a serious crime. Organ transplantation is typically performed with a brain-dead patient whose other organs are healthy and can be used to save another person's life. The Organ Transplantation Market , share is expected to grow USD 12.4 billion compound annual growth rate of 9.50% during the period of forecast 2022-2030. This procedure is performed to treat organ failure in the lungs, liver, kidneys, and many others. Kidney is the most broadly transplanted organ followed by the liver. Unfortunately, the demand for organ donations is even more significant than the

  Market Insights: Market Research Future (MRFR)’s latest study asserts that the global Small Molecule API Market size was valued at USD 173.5 billion in 2022. The small molecule API industry is projected to grow from USD 185.6 billion in 2023 to USD 278.6 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 7.00% during the forecast period (2023 - 2030). The increased investments in the research & findings coupled with government support are likely to propel the market growth in the forthcoming years. Some of the factors responsible for favoring the expansion of the Small Molecule API Market include growing demand for small molecule drugs, rising access to the medication in developing and underdeveloped countries, entry of big CMOs into the market, etc. Furthermore, rising burden of cardiovascular diseases and cancer is forecasted to intensify the competition among the players of the small molecule api manufacturing companies market. According to the Ameri